MedPath

NEOMEDLIGHT

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Efficacy and Safety of CareMin650 for Prevention of Oral Mucositis in HNC Patients Starting Radiotherapy

Not Applicable
Completed
Conditions
Head and Neck Cancer
Oral Mucositis (Ulcerative) Due to Radiation
Radiation Therapy Complication
First Posted Date
2021-01-07
Last Posted Date
2022-10-10
Lead Sponsor
NeoMedLight
Target Recruit Count
15
Registration Number
NCT04699487
Locations
🇩🇪

UNIKLINIK RWTH AACHEN - Klinik für Radioonkologie und Strahlentherapie, Aachen, Germany

Feasibility and Safety of CareMin650 in Patients at Risk of or Suffering From Oral Mucositis and/or Radiation Dermatitis

Not Applicable
Completed
Conditions
Radiation Dermatitis
Oral Mucositis Due to Radiation
First Posted Date
2019-06-17
Last Posted Date
2021-04-30
Lead Sponsor
NeoMedLight
Target Recruit Count
72
Registration Number
NCT03988556
Locations
🇫🇷

Institut de radiothérapie et radiochirurgie Hartmann, Levallois-Perret, France

🇫🇷

Centre Oscar Lambret, Lille, France

🇫🇷

Centre de Haute Energie, Nice, France

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.